Clinical trial • Phase I • Oncology
JNJ-89402638 for Metastatic colorectal cancer | Gastric cancer
Phase I trial of JNJ-89402638 for Metastatic colorectal cancer | Gastric cancer. None/Not specified-controlled. 140 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Metastatic colorectal cancer | Gastric cancer
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 16-09-2024
- First CTIS Authorization Date
- 11-12-2024
Trial design
None/Not specified-controlled Phase I trial across 4 sites in Spain.
- Comparator
- None/Not specified
- Target Sample Size
- 140
Recruitment
- Planned Sample Size
- 140
- Recruitment Window Months
- 42
Geography
- Total Number Of Sites
- 4
- Total Number Of Participants
- 140
Spain
- Earliest CTIS Part Ii Submission Date
- 08-11-2024
- Latest Decision Or Authorization Date
- 27-04-2026
- Processing Time Days
- 535
- Number Of Sites
- 4
- Number Of Participants
- 80
Sites
- Site Name
- Hospital Universitario Fundacion Jimenez Diaz
- Department Name
- Oncology
- Principal Investigator Name
- Victor Moreno Garcia
- Principal Investigator Email
- victor.moreno@startmadrid.com
- Contact Person Name
- Victor Moreno Garcia
- Contact Person Email
- victor.moreno@startmadrid.com
- Site Name
- Hospital Universitario Hm Sanchinarro
- Department Name
- Medical Oncology
- Principal Investigator Name
- Emiliano Calvo
- Principal Investigator Email
- emiliano.calvo@startmadrid.com
- Contact Person Name
- Emiliano Calvo
- Contact Person Email
- emiliano.calvo@startmadrid.com
- Site Name
- Hospital Universitari Vall D Hebron
- Department Name
- Medical Oncology
- Principal Investigator Name
- Elena Elez
- Principal Investigator Email
- meelez@vhio.net
- Contact Person Name
- Elena Elez
- Contact Person Email
- meelez@vhio.net
- Site Name
- Hospital Universitario 12 De Octubre
- Department Name
- Medical Oncology
- Principal Investigator Name
- Jorge Barriuso Feijoo
- Principal Investigator Email
- jorge.barriuso.imas12@h12o.es
- Contact Person Name
- Jorge Barriuso Feijoo
- Contact Person Email
- jorge.barriuso.imas12@h12o.es
Sponsor
Primary sponsor
- Full Name
- Janssen Cilag International
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Belgium
Investigational products
- Investigational Product Name
- JNJ-89402638
Related trials
Other published trials that may interest you.
- GDC-9545 for Locally advanced or metastatic estrogen receptor-positive breast cancer
- Abemaciclib for Stage IV lung cancer | Breast cancer
- BGB-43395 for Advanced or metastatic solid tumors | Hormone receptor positive HER2 negative breast cancer
- AZD9833 for Estrogen receptor-positive HER2-negative advanced breast cancer
- Pembrolizumab for Classical Hodgkin lymphoma | Melanoma | Solid tumours (MSI-H/dMMR) | Solid tumours (TMB-H)